News | August 23, 2023
Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
Eris Lifesciences enters into term loan agreement with Citi Bank
Eris Lifesciences enters into term loan agreement with Citi Bank
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
CiplaMed 2.0 leverages advanced analytics and automation
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
